Parametric Portfolio Associates LLC lifted its position in shares of Humana Inc. (NYSE:HUM) by 50.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 413,778 shares of the insurance provider’s stock after buying an additional 139,330 shares during the period. Parametric Portfolio Associates LLC owned about 0.29% of Humana worth $99,563,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Guardian Life Insurance Co. of America raised its holdings in shares of Humana by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares in the last quarter. Reliance Trust Co. of Delaware raised its holdings in shares of Humana by 0.7% during the 2nd quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock valued at $270,000 after buying an additional 8 shares in the last quarter. Creative Planning raised its holdings in shares of Humana by 0.3% during the 2nd quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after buying an additional 15 shares in the last quarter. Cadence Capital Management LLC raised its holdings in shares of Humana by 0.4% during the 2nd quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock valued at $1,367,000 after buying an additional 22 shares in the last quarter. Finally, Sit Investment Associates Inc. raised its holdings in shares of Humana by 0.3% during the 2nd quarter. Sit Investment Associates Inc. now owns 12,020 shares of the insurance provider’s stock valued at $2,892,000 after buying an additional 40 shares in the last quarter. 95.12% of the stock is currently owned by institutional investors.

Humana Inc. (NYSE:HUM) traded up 0.19% during midday trading on Friday, hitting $239.09. The company had a trading volume of 1,343,101 shares. The stock has a 50 day moving average price of $250.95 and a 200 day moving average price of $232.23. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $259.76. The company has a market capitalization of $34.55 billion, a P/E ratio of 19.67 and a beta of 0.87.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same period in the prior year, the business posted $2.30 earnings per share. Equities analysts forecast that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.67%. Humana’s payout ratio is 13.06%.

WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/parametric-portfolio-associates-llc-increases-position-in-humana-inc-hum/1585118.html.

A number of equities analysts have commented on HUM shares. UBS AG reaffirmed a “neutral” rating and issued a $250.00 price target (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Zacks Investment Research cut Humana from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price target on shares of Humana in a research note on Friday, July 14th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $223.00 price target (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $246.60.

In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now directly owns 14,258 shares in the company, valued at approximately $3,421,920. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider William Kevin Fleming sold 3,071 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the transaction, the insider now owns 7,681 shares in the company, valued at $1,927,777.38. The disclosure for this sale can be found here. Over the last quarter, insiders sold 60,566 shares of company stock worth $15,326,746. Company insiders own 0.80% of the company’s stock.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.